血浆NT-proBNP检测在COPD合并呼吸衰竭患者中的临床意义

Clinical Significance of Plasma NT-proBNP Testing in COPD Patients with Respiratory Failure

目的通过测定COPD合并呼吸衰竭患者血浆NT-proBNP数值水平,探讨其临床价值。方法采用电化学发光免疫学方法测定COPD呼衰患者和COPD非呼吸衰竭患者治疗前血浆NT-proBNP水平。结果 COPD呼吸衰竭患者血浆NT-proBNP数值水平高于COPD非呼衰患者。结论 COPD合并呼吸衰竭患者血浆NT-proBNP数值水平明显升高提示存在早期和(或)轻度右心功能不全,应引起临床医生重视。

Objective To discuss the clinical value By measuring the level of plasma NT-proBNP values in the COPD patients with respiratory failure.Methods Immunological methods using electrochemical luminescence determination,the plasma NT-proBNP levels before treatment of COPD patients with respiratory failure and COPD patients with non-respiratory failure.Results Plasma NT-proBNP value of COPD patients with respiratory failure was higher than that of COPD patients with non-respiratory failure.Conclusion COPD patients with respiratory failure,plasma NT-proBNP levels were significantly higher value suggest the presence of early and （or） mild right ventricular dysfunction,clinicians should cause attention.